List of Excipients in API nadofaragene firadenovec-vncg
✉ Email this page to a colleague
Detailed excipient profiles for nadofaragene firadenovec-vncg
Excipient focus: (N-(3-CHOLAMIDOPROPYL)-N-(3-LACTOBIONAMIDOPROPYL))CHOLAMIDE
nadofaragene firadenovec-vncg drug variants containing (N-(3-CHOLAMIDOPROPYL)-N-(3-LACTOBIONAMIDOPROPYL))CHOLAMIDE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing (N-(3-CHOLAMIDOPROPYL)-N-(3-LACTOBIONAMIDOPROPYL))CHOLAMIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
nadofaragene firadenovec-vncg drug variants containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing CITRIC ACID MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
nadofaragene firadenovec-vncg drug variants containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing GLYCERIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL BETADEX
nadofaragene firadenovec-vncg drug variants containing HYDROXYPROPYL BETADEX
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing HYDROXYPROPYL BETADEX
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
nadofaragene firadenovec-vncg drug variants containing MAGNESIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing MAGNESIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
nadofaragene firadenovec-vncg drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
nadofaragene firadenovec-vncg drug variants containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
nadofaragene firadenovec-vncg drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
nadofaragene firadenovec-vncg drug variants containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TROMETHAMINE
nadofaragene firadenovec-vncg drug variants containing TROMETHAMINE
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing TROMETHAMINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
nadofaragene firadenovec-vncg drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Ferring Pharmaceuticals | nadofaragene firadenovec-vncg | 55566-1050 |
>Company | >Ingredient | >NDC |
nadofaragene firadenovec-vncg drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.